Agios Pharma's total assets for Q2 2026 were $1.11B, a decrease of -6.46% from the previous quarter. MX:AGIO total liabilities were $82.40M for the fiscal quarter, a 8.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.